Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis

Alleviating anemia and thrombocytopenia in myelofibrosis patients

(2016) Francisco Cervantes et al.   Expert Review of Hematology

Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study

(2014) Caterina Tatarelli et al.   ANNALS OF HEMATOLOGY

How I treat myelofibrosis

(2014) F. Cervantes   BLOOD

Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

(2013) A. Tefferi et al.   BLOOD

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

(2013) V. Santini et al.   BLOOD

JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis

(2012) Claire Harrison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes

(2011) S. W. Smith et al.   HAEMATOLOGICA

Prognostication in Primary Myelofibrosis

(2011) Francisco Cervantes et al.   Current Hematologic Malignancy Reports

Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients

(2010) Alejandra Martínez-Trillos et al.   ANNALS OF HEMATOLOGY

What are RBC-transfusion-dependence and -independence?

(2010) R.P. Gale et al.   LEUKEMIA RESEARCH

How I treat patients with myelodysplastic syndromes

(2009) R. M. Stone   BLOOD

Thrombosis in primary myelofibrosis: incidence and risk factors

(2009) T. Barbui et al.   BLOOD

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

(2009) F. Passamonti et al.   BLOOD

Erythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level

(2009) Jocelin Huang et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Erythropoietin in Cancer Patients

(2008) John A. Glaspy   Annual Review of Medicine

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

(2008) F. Cervantes et al.   BLOOD